z-logo
open-access-imgOpen Access
Antimicrobial Susceptibility Testing of Chlamydia trachomatis Using a Reverse Transcriptase PCR-Based Method
Author(s) -
Neil A. Cross,
D J Kellock,
G R Kinghorn,
Maria Taraktchoglou,
E. Bataki,
Kevin M. Oxley,
Peter M. Hawkey,
A. Eley
Publication year - 1999
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.43.9.2311
Subject(s) - chlamydia trachomatis , antimicrobial , erythromycin , reverse transcriptase , biology , microbiology and biotechnology , chlamydia , virology , antibiotics , polymerase chain reaction , immunology , gene , genetics
The conventional method for antimicrobial susceptibility testing ofChlamydia trachomatis is subjective and potentially misleading. We have developed a reverse transcriptase PCR (RT-PCR)-based method which is more sensitive and less subjective than the conventional method. Using 16 strains ofC. trachomatis in triplicate assays, we found the RT-PCR method consistently more sensitive than the conventional technique for all eight antimicrobials tested, with resultant MICs determined by RT-PCR ranging from 1.6-fold higher (erythromycin) to ≥195-fold higher (amoxicillin).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom